Polyvalent Streptococcus Pneumococcal Vaccines Market, Global Outlook and Forecast 2022-2028
The polyvalent streptococcus pneumoniae vaccine is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
This report contains market size and forecasts of Polyvalent Streptococcus Pneumococcal Vaccines in global, including the following market information:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Polyvalent Streptococcus Pneumococcal Vaccines companies in 2021 (%)
The global Polyvalent Streptococcus Pneumococcal Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
9-Valent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines include GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polyvalent Streptococcus Pneumococcal Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Type, 2021 (%)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Application, 2021 (%)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues share in global market, 2021 (%)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Polyvalent Streptococcus Pneumococcal Vaccines in global, including the following market information:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Polyvalent Streptococcus Pneumococcal Vaccines companies in 2021 (%)
The global Polyvalent Streptococcus Pneumococcal Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
9-Valent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines include GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polyvalent Streptococcus Pneumococcal Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polyvalent Streptococcus Pneumococcal Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Type, 2021 (%)
- 9-Valent
- 13-Valent
- 23-Valent
- Others
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Community Clinics
- Public Health Agencies
- Others
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines revenues share in global market, 2021 (%)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Polyvalent Streptococcus Pneumococcal Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- LG Chem
- Merck
- Panacea Biotec
- AstraZeneca
- Pfizer
- Shire
- Pnuvax Incorporated
- Serum Institute
- Shinogi
- Shenzhen Kangtai Biological Products
- SK Bioscience
- Walvax Biotechnology
- Eli Lilly
- Abera
- Sanofi
- Genentech
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Polyvalent Streptococcus Pneumococcal Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES OVERALL MARKET SIZE
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2021 VS 2028
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.2 Top Global Polyvalent Streptococcus Pneumococcal Vaccines Companies Ranked by Revenue
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies
3.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies
3.5 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Polyvalent Streptococcus Pneumococcal Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Markets, 2021 & 2028
4.1.2 9-Valent
4.1.3 13-Valent
4.1.4 23-Valent
4.1.5 Others
4.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
4.2.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
4.3.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
4.3.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
4.3.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Community Clinics
5.1.4 Public Health Agencies
5.1.5 Others
5.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
5.2.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
5.3.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
5.3.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
5.3.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
6.2.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
6.3.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
6.3.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
6.3.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.4.3 US Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.4.4 Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.4.5 Mexico Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.5.3 Germany Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.4 France Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.5 U.K. Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.6 Italy Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.7 Russia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.9 Benelux Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.6.3 China Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.4 Japan Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.5 South Korea Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.7 India Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.7.3 Brazil Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.7.4 Argentina Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.8.3 Turkey Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.4 Israel Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.6 UAE Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 LG Chem
7.2.1 LG Chem Corporate Summary
7.2.2 LG Chem Business Overview
7.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.2.4 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 LG Chem Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.3.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Panacea Biotec
7.4.1 Panacea Biotec Corporate Summary
7.4.2 Panacea Biotec Business Overview
7.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.4.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Panacea Biotec Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.5.4 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.6.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Shire
7.7.1 Shire Corporate Summary
7.7.2 Shire Business Overview
7.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.7.4 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Shire Key News
7.8 Pnuvax Incorporated
7.8.1 Pnuvax Incorporated Corporate Summary
7.8.2 Pnuvax Incorporated Business Overview
7.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.8.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Pnuvax Incorporated Key News
7.9 Serum Institute
7.9.1 Serum Institute Corporate Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.9.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Serum Institute Key News
7.10 Shinogi
7.10.1 Shinogi Corporate Summary
7.10.2 Shinogi Business Overview
7.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.10.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Shinogi Key News
7.11 Shenzhen Kangtai Biological Products
7.11.1 Shenzhen Kangtai Biological Products Corporate Summary
7.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.11.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Shenzhen Kangtai Biological Products Key News
7.12 SK Bioscience
7.12.1 SK Bioscience Corporate Summary
7.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.12.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 SK Bioscience Key News
7.13 Walvax Biotechnology
7.13.1 Walvax Biotechnology Corporate Summary
7.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.13.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 Walvax Biotechnology Key News
7.14 Eli Lilly
7.14.1 Eli Lilly Corporate Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.14.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 Eli Lilly Key News
7.15 Abera
7.15.1 Abera Corporate Summary
7.15.2 Abera Business Overview
7.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.15.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Abera Key News
7.16 Sanofi
7.16.1 Sanofi Corporate Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.16.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Sanofi Key News
7.17 Genentech
7.17.1 Genentech Corporate Summary
7.17.2 Genentech Business Overview
7.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.17.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Genentech Key News
8 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity, 2017-2028
8.2 Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES SUPPLY CHAIN ANALYSIS
10.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
10.2 Polyvalent Streptococcus Pneumococcal Vaccines Upstream Market
10.3 Polyvalent Streptococcus Pneumococcal Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Polyvalent Streptococcus Pneumococcal Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES OVERALL MARKET SIZE
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2021 VS 2028
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.2 Top Global Polyvalent Streptococcus Pneumococcal Vaccines Companies Ranked by Revenue
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies
3.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies
3.5 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Polyvalent Streptococcus Pneumococcal Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Markets, 2021 & 2028
4.1.2 9-Valent
4.1.3 13-Valent
4.1.4 23-Valent
4.1.5 Others
4.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
4.2.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
4.3.1 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
4.3.2 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
4.3.3 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Community Clinics
5.1.4 Public Health Agencies
5.1.5 Others
5.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
5.2.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
5.3.1 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
5.3.2 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
5.3.3 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue & Forecasts
6.2.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales & Forecasts
6.3.1 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2022
6.3.2 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2023-2028
6.3.3 By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.4.3 US Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.4.4 Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.4.5 Mexico Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.5.3 Germany Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.4 France Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.5 U.K. Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.6 Italy Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.7 Russia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.5.9 Benelux Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.6.3 China Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.4 Japan Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.5 South Korea Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.6.7 India Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.7.3 Brazil Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.7.4 Argentina Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, 2017-2028
6.8.3 Turkey Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.4 Israel Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
6.8.6 UAE Polyvalent Streptococcus Pneumococcal Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 LG Chem
7.2.1 LG Chem Corporate Summary
7.2.2 LG Chem Business Overview
7.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.2.4 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 LG Chem Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.3.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Panacea Biotec
7.4.1 Panacea Biotec Corporate Summary
7.4.2 Panacea Biotec Business Overview
7.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.4.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Panacea Biotec Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.5.4 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.6.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Shire
7.7.1 Shire Corporate Summary
7.7.2 Shire Business Overview
7.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.7.4 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Shire Key News
7.8 Pnuvax Incorporated
7.8.1 Pnuvax Incorporated Corporate Summary
7.8.2 Pnuvax Incorporated Business Overview
7.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.8.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Pnuvax Incorporated Key News
7.9 Serum Institute
7.9.1 Serum Institute Corporate Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.9.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Serum Institute Key News
7.10 Shinogi
7.10.1 Shinogi Corporate Summary
7.10.2 Shinogi Business Overview
7.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.10.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Shinogi Key News
7.11 Shenzhen Kangtai Biological Products
7.11.1 Shenzhen Kangtai Biological Products Corporate Summary
7.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.11.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Shenzhen Kangtai Biological Products Key News
7.12 SK Bioscience
7.12.1 SK Bioscience Corporate Summary
7.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.12.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 SK Bioscience Key News
7.13 Walvax Biotechnology
7.13.1 Walvax Biotechnology Corporate Summary
7.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Business Overview
7.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.13.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 Walvax Biotechnology Key News
7.14 Eli Lilly
7.14.1 Eli Lilly Corporate Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.14.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 Eli Lilly Key News
7.15 Abera
7.15.1 Abera Corporate Summary
7.15.2 Abera Business Overview
7.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.15.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Abera Key News
7.16 Sanofi
7.16.1 Sanofi Corporate Summary
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.16.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Sanofi Key News
7.17 Genentech
7.17.1 Genentech Corporate Summary
7.17.2 Genentech Business Overview
7.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Major Product Offerings
7.17.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Genentech Key News
8 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity, 2017-2028
8.2 Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES SUPPLY CHAIN ANALYSIS
10.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
10.2 Polyvalent Streptococcus Pneumococcal Vaccines Upstream Market
10.3 Polyvalent Streptococcus Pneumococcal Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Polyvalent Streptococcus Pneumococcal Vaccines in Global Market
Table 2. Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
Table 9. List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 48. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. LG Chem Corporate Summary
Table 50. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 51. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 54. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Panacea Biotec Corporate Summary
Table 56. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 57. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 60. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 63. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shire Corporate Summary
Table 65. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 66. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Pnuvax Incorporated Corporate Summary
Table 68. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 69. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Serum Institute Corporate Summary
Table 71. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 72. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shinogi Corporate Summary
Table 74. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 75. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Shenzhen Kangtai Biological Products Corporate Summary
Table 77. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 78. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. SK Bioscience Corporate Summary
Table 80. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 81. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Walvax Biotechnology Corporate Summary
Table 83. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 84. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Eli Lilly Corporate Summary
Table 86. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 87. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Abera Corporate Summary
Table 89. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 90. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sanofi Corporate Summary
Table 92. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 93. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Genentech Corporate Summary
Table 95. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 96. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 98. Global Polyvalent Streptococcus Pneumococcal Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 99. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2017-2022 (K Units)
Table 100. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2023-2028 (K Units)
Table 101. Polyvalent Streptococcus Pneumococcal Vaccines Market Opportunities & Trends in Global Market
Table 102. Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers in Global Market
Table 103. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints in Global Market
Table 104. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials
Table 105. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials Suppliers in Global Market
Table 106. Typical Polyvalent Streptococcus Pneumococcal Vaccines Downstream
Table 107. Polyvalent Streptococcus Pneumococcal Vaccines Downstream Clients in Global Market
Table 108. Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of Polyvalent Streptococcus Pneumococcal Vaccines in Global Market
Table 2. Top Polyvalent Streptococcus Pneumococcal Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Companies, (K Units), 2017-2022
Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Type
Table 9. List of Global Tier 1 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polyvalent Streptococcus Pneumococcal Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 15. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 16. By Application – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 20. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 21. By Region – Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2017-2022
Table 25. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), 2023-2028
Table 26. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 29. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 30. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 33. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 34. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 37. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 41. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 48. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. LG Chem Corporate Summary
Table 50. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 51. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 54. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Panacea Biotec Corporate Summary
Table 56. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 57. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 60. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 63. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shire Corporate Summary
Table 65. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 66. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Pnuvax Incorporated Corporate Summary
Table 68. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 69. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Serum Institute Corporate Summary
Table 71. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 72. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shinogi Corporate Summary
Table 74. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 75. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Shenzhen Kangtai Biological Products Corporate Summary
Table 77. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 78. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. SK Bioscience Corporate Summary
Table 80. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 81. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Walvax Biotechnology Corporate Summary
Table 83. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 84. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Eli Lilly Corporate Summary
Table 86. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 87. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Abera Corporate Summary
Table 89. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 90. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Sanofi Corporate Summary
Table 92. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 93. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Genentech Corporate Summary
Table 95. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Offerings
Table 96. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 98. Global Polyvalent Streptococcus Pneumococcal Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 99. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2017-2022 (K Units)
Table 100. Global Polyvalent Streptococcus Pneumococcal Vaccines Production by Region, 2023-2028 (K Units)
Table 101. Polyvalent Streptococcus Pneumococcal Vaccines Market Opportunities & Trends in Global Market
Table 102. Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers in Global Market
Table 103. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints in Global Market
Table 104. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials
Table 105. Polyvalent Streptococcus Pneumococcal Vaccines Raw Materials Suppliers in Global Market
Table 106. Typical Polyvalent Streptococcus Pneumococcal Vaccines Downstream
Table 107. Polyvalent Streptococcus Pneumococcal Vaccines Downstream Clients in Global Market
Table 108. Polyvalent Streptococcus Pneumococcal Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type
Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application
Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Polyvalent Streptococcus Pneumococcal Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2021
Figure 9. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 19. US Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 33. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Polyvalent Streptococcus Pneumococcal Vaccines by Region, 2021 VS 2028
Figure 50. Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type
Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application
Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Polyvalent Streptococcus Pneumococcal Vaccines Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2021
Figure 9. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Polyvalent Streptococcus Pneumococcal Vaccines Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 19. US Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 33. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Polyvalent Streptococcus Pneumococcal Vaccines Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Polyvalent Streptococcus Pneumococcal Vaccines by Region, 2021 VS 2028
Figure 50. Polyvalent Streptococcus Pneumococcal Vaccines Industry Value Chain
Figure 51. Marketing Channels
